-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Amicus Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q2 2024.
- Amicus Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 304M shares, a 3.75% increase year-over-year.
- Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 295M shares, a 2.11% increase from 2022.
- Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 289M shares, a 6.5% increase from 2021.
- Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 271M shares, a 4.85% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)